Carregant...
Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1
BACKGROUND: Serotonin type 3 receptor (5-HT(3)R) antagonists are potentially useful therapeutic agents for diarrhea-predominant irritable bowel syndrome (IBS-D). AIM: To identify biomarkers predicting effectiveness of the 5-HT(3)R antagonist (ramosetron) in IBS-D. METHODS: IBS-D Japanese subjects re...
Guardat en:
| Publicat a: | Neurogastroenterol Motil |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4285583/ https://ncbi.nlm.nih.gov/pubmed/25428414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/nmo.12473 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|